Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Surgeon hails new CABG technology as a 'technical breakthrough'

Distal anastomoses are almost exclusively hand-sewn as a current standard of care, which limits the widespread implementation of less-invasive approaches. This trial looked at the ability of the ELANA device to more easily construct distal anastomoses in CABG.

The new-look ELANA device from AMT Medical could simplify CABG procedures and help improve patient access to minimally invasive and robotic surgical techniques.

  • Read more about Surgeon hails new CABG technology as a 'technical breakthrough'

Failure to rescue after TAVR: New study tracks outcomes at high- and low-volume hospitals

cardiologist viewing heart data

High-volume hospitals are often associated with better TAVR outcomes. The team behind this new study wanted to see if a similar trend was seen with FTR rates as well. 

  • Read more about Failure to rescue after TAVR: New study tracks outcomes at high- and low-volume hospitals

Cardiologist named chief medical officer of wearable tech company Whoop

Ami B. Bhatt, MD, a veteran cardiologist and digital health specialist, is the new chief medical officer of Whoop, a Boston-based wearable tech company.

Ami B. Bhatt, MD, and Whoop founder Will Ahmed. Image courtesy of Whoop.

Ami B. Bhatt, MD, a veteran cardiologist and digital health specialist, stepped down as the American College of Cardiology's chief innovation officer to accept this new role. 

  • Read more about Cardiologist named chief medical officer of wearable tech company Whoop

FDA sees early promise in new gene therapy for BAG3-associated DCM

pharmaceutical drug approval process

An investigational drug therapy from Affinia Therapeutics has secured the FDA's orphan drug designation. This means the company now has access to certain benefits, including tax credits and fee exemptions, as it works toward approval. 

  • Read more about FDA sees early promise in new gene therapy for BAG3-associated DCM

Less invasive anesthesia strategies during TAVR linked to a key benefit

cardiologists heart doctors

Long-term TAVR outcomes were comparable. When tracking 30-day data, however, researchers found that hospital readmission was much less common for patients treated with regional anesthesia or moderate sedation.

  • Read more about Less invasive anesthesia strategies during TAVR linked to a key benefit

Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

A gavel and a stethoscope

Novo Nordisk filed a lawsuit claiming Eli Lilly ran “false and materially misleading” advertisements that ignore recent data. According to Lilly, though, its message is "truthful" and "grounded in the most direct scientific evidence available."

  • Read more about Novo Nordisk sues GLP-1 rival Eli Lilly over claims of false advertising

Steerable sheaths for PFA recalled due to safety risk

FDA recall medical device recall product recall

More than 750,000 devices are included in the new Class II recall. At this time, however, no devices need to be returned to the manufacturer. 

  • Read more about Steerable sheaths for PFA recalled due to safety risk

More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

Continuous and high-adherent statin users had lower baseline arterial stiffness which also grew more slowly over time, a new JAMA Network Open study finds.

Thanks to updated guidelines published in March, an additional 21.5 million adults between the ages of 30 and 79 are now eligible for statins. Researchers did emphasize that lifestyle changes are another effective way to reduce ASCVD risk. 

  • Read more about More than half of U.S. adults now eligible for statin therapy under new cholesterol guidelines

FDA shares warning about certain IV administration sets—heart patients face greatest risk

warning safety alert recall healthcare issue

In most cases, the issue should not cause harm. However, patients with a patent foramen ovale or other right-to-left shunts may face an increased risk of a heart attack or stroke.

  • Read more about FDA shares warning about certain IV administration sets—heart patients face greatest risk

How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

old elderly couple coffee drink retired love romance man

Drinking multiple cups of coffee each day may decrease a person's risk of heart disease, heart failure and stroke. However, too much caffeine can still cause issues.

  • Read more about How much coffee is safe for the heart? Doctors explore the benefits and risks of caffeine

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page …21
    • Page 22
    • Page 23
    • Page 24
    • Current page 25
    • Page 26
    • Page 27
    • Page 28
    • Page 29 …
    • Next page Next ›
    • Last page Last »
Subscribe
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme